Stay updated on PD1-LAG3 Bispecific Dose Escalation Clinical Trial

Sign up to get notified when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-02T16:26:08.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner was added announcing the NIH website transition and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    0.3%
    Check dated 2026-10-26T16:47:38.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-19T21:48:01.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer's displayed site revision was updated from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-13T04:16:09.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new page revision tag v3.7.0 was added to the record history, and the previous v3.6.6 entry was removed, reflecting an update to the page's revision status in the study record history.
    Difference
    0.0%
    Check dated 2026-09-21T22:24:14.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The latest update adds a 'Study Status' entry to the record history (Version 74, dated 2026-09-11), reflecting an update to the study's current status.
    Difference
    0.2%
    Check dated 2026-09-14T20:02:04.000Z thumbnail image

Stay in the know with updates to PD1-LAG3 Bispecific Dose Escalation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.